189 related articles for article (PubMed ID: 11508781)
1. Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study.
Fulghesu AM; Ciampelli M; Belosi C; Apa R; Guido M; Caruso A; Mancuso S; Lanzone A
J Endocrinol Invest; 2001; 24(7):483-90. PubMed ID: 11508781
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
3. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
4. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
[TBL] [Abstract][Full Text] [Related]
5. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
[TBL] [Abstract][Full Text] [Related]
6. The use of gonadotrophin-releasing hormone antagonists in polycystic ovarian disease.
Lubin V; Charbonnel B; Bouchard P
Baillieres Clin Obstet Gynaecol; 1998 Dec; 12(4):607-18. PubMed ID: 10627771
[TBL] [Abstract][Full Text] [Related]
7. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
Tan SL; Farhi J; Homburg R; Jacobs HS
Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
[TBL] [Abstract][Full Text] [Related]
8. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
Couzinet B; Young J; Brailly S; Chanson P; Schaison G
J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome.
Timmerman-van Kessel EC; Cikot RJ; Dargel-Donkers EJ; Zwertbroek W; van Dop PA; Schoot DC
Fertil Steril; 2000 Jun; 73(6):1145-8. PubMed ID: 10856472
[TBL] [Abstract][Full Text] [Related]
10. Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome.
Cagnacci A; Soldani R; Paoletti AM; Falqui A; Melis GB
Fertil Steril; 1994 Aug; 62(2):269-72. PubMed ID: 8034071
[TBL] [Abstract][Full Text] [Related]
11. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.
Bayram N; van Wely M; Vandekerckhove P; Lilford R; van Der Veen F
Cochrane Database Syst Rev; 2000; (2):CD000412. PubMed ID: 10796718
[TBL] [Abstract][Full Text] [Related]
12. Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome.
Guido M; Pavone V; Ciampelli M; Murgia F; Fulghesu AM; Apa R; Caruso A; Mancuso S; Lanzone A
J Clin Endocrinol Metab; 1998 May; 83(5):1742-5. PubMed ID: 9589685
[TBL] [Abstract][Full Text] [Related]
13. Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction.
Filicori M; Flamigni C; Cognigni G; Dellai P; Michelacci L; Arnone R
Fertil Steril; 1994 Aug; 62(2):279-85. PubMed ID: 8034073
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion.
Lanzone A; Fulghesu AM; Cucinelli F; Ciampelli M; Caruso A; Mancuso S
J Clin Endocrinol Metab; 1995 Dec; 80(12):3501-6. PubMed ID: 8530590
[TBL] [Abstract][Full Text] [Related]
15. Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone.
Schachter M; Balen AH; Patel A; Jacobs HS
Gynecol Endocrinol; 1996 Oct; 10(5):327-35. PubMed ID: 8915662
[TBL] [Abstract][Full Text] [Related]
16. Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.
Corenthal L; Von Hagen S; Larkins D; Ibrahim J; Santoro N
Fertil Steril; 1994 Jun; 61(6):1027-33. PubMed ID: 8194612
[TBL] [Abstract][Full Text] [Related]
17. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].
Kuroda G
Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):247-59. PubMed ID: 3111899
[TBL] [Abstract][Full Text] [Related]
18. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
19. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
[TBL] [Abstract][Full Text] [Related]
20. Prospective, randomized comparison between pulsatile GnRH therapy and combined gonadotropin (FSH+LH) treatment for ovulation induction in women with hypothalamic amenorrhea and underlying polycystic ovary syndrome.
Dubourdieu S; Fréour T; Dessolle L; Barrière P
Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):45-8. PubMed ID: 23298894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
